Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Postma

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
European Journal of Endocrinology|January 18, 2012
Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegalyMark R Postma, Romana T Netea-Maier, Gerrit van den Berg, et al.
Science Translational Medicine|September 21, 2012
Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofenChristina Henderson, Lasani Wijetunge, Mika Nakamoto Kinoshita, et al.
BMJ Open|October 8, 2021
Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trialRob A Vergeer, Mark R Postma, Iris Schmidt, et al.
European Journal of Endocrinology|November 8, 2018
Postoperative use of somatostatin analogs and mortality in patients with acromegalyMark R Postma, Thalijn L C Wolters, Gerrit van den Berg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2024
Fluorescence detection of pituitary neuroendocrine tumour during endoscopic transsphenoidal surgery using bevacizumab-800CW: a non-randomised, non-blinded, single centre feasibility and dose finding trial [DEPARTURE trial]I Schmidt, R A Vergeer, M R Postma, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
European Journal of Endocrinology|January 18, 2012
Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegalyMark R Postma, Romana T Netea-Maier, Gerrit van den Berg, et al.
Science Translational Medicine|September 21, 2012
Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofenChristina Henderson, Lasani Wijetunge, Mika Nakamoto Kinoshita, et al.
BMJ Open|October 8, 2021
Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trialRob A Vergeer, Mark R Postma, Iris Schmidt, et al.
European Journal of Endocrinology|November 8, 2018
Postoperative use of somatostatin analogs and mortality in patients with acromegalyMark R Postma, Thalijn L C Wolters, Gerrit van den Berg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2024
Fluorescence detection of pituitary neuroendocrine tumour during endoscopic transsphenoidal surgery using bevacizumab-800CW: a non-randomised, non-blinded, single centre feasibility and dose finding trial [DEPARTURE trial]I Schmidt, R A Vergeer, M R Postma, et al.
Pageof 7